L-carnitine Drug Interactions, Uses, Effectiveness, Safety & More
What is this page for?
First and foremost: how L-carnitine interacts with medications. The heart of this page is the interaction list — every drug L-carnitine is known to interact with, and how serious each one is.
But these pages have grown well beyond that into a full monograph — what L-carnitine is, what people use it for and how strong the evidence is, its safety and side effects, and answers to the questions we’re asked most — written and reviewed by the clinical staff at HelloPharmacist. It’s educational information from our licensed clinical databases, not medical advice, and we don’t sell or endorse products. Our editorial policy
Check L-carnitine against your medication
Add one medicationL-carnitine Drug Interactions: The Bottom Line
From the HelloPharmacist Editorial Team · Updated July 2026Based on the available evidence, the overall risk of a clinically significant L-carnitine drug interaction appears low for most people, though a few medications deserve real attention. None of the listed interactions are rated major, and most rest on theoretical reasoning or scattered case reports rather than strong human studies.
The best-documented concern involves thyroid hormone replacement. L-carnitine appears to work against thyroid hormone in the body's tissues, which could make thyroid treatment less effective, and this is supported by human research. Blood thinners are the other standout: with acenocoumarol there are case reports of blood becoming thinner than intended, and a similar effect with warfarin is plausible even though it has not been confirmed. Because bleeding risk is closely monitored with these medicines, even a modest shift matters.
L-carnitine sits on a fairly long list of interacting medications, but a long list does not mean every combination causes harm. Outside the thyroid and blood-thinner concerns, most entries reflect theoretical predictions or limited reports, and predicted effects have often not been proven to cause meaningful changes in people.
Based on HelloPharmacist’s L-carnitine interaction data and reviewed under our editorial standards.
Drugs that interact with L-carnitine
19 medications have a known interaction with L-carnitine, graded by severity. Select any drug for the full evidence-based detail.
Don’t want to scroll the list? Just ask.
Tell us the medications you take and we’ll check each one against L-carnitine using our pharmacist-reviewed interaction data.
AI summaries are generated from our L-carnitine interaction data for education only — always confirm with your pharmacist. How we use AI
No drugs match “”.
What Severity, Likelihood & Evidence Mean
Severity — How Serious It Can Be
- Major. Clinically significant; generally best avoided, or used only under direct professional supervision.
- Moderate. May need monitoring, a dose adjustment, or separating the times you take each one.
- Minor. Generally not clinically significant, but still worth noting and mentioning to your pharmacist.
- No known interaction. Checked against our sources with nothing documented — not the same as proven safety.
Likelihood — How Well It’s Documented
- Likely. Well-controlled human studies have demonstrated the likely existence of this interaction
- Probable. Interaction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
- Possible. Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists
- Unlikely. Interaction has been demonstrated in animal or in lab research but has been shown not to occur in humans.
Where This Data Comes From
- Interaction records are evidence-graded and sourced from the Natural Medicines database (TRC Healthcare), the same reference used by pharmacists and hospitals.
- Each drug listed above links to the full report for that exact L-carnitine combination — clinical detail, likelihood, evidence level, and citations.
- Content is reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
The kinds of drugs L-carnitine affects
Every type of medication (drug category) L-carnitine is known to interact with. Open any category for the detail — or search your exact drug in the checker above.
Acenocoumarol (Sintrom)
Theoretically, L-carnitine might increase the anticoagulant effects of acenocoumarol.
L-carnitine might enhance the anticoagulant effects of acenocoumarol, an oral anticoagulant similar to warfarin, but shorter-acting. There are at least two case reports of INR elevation with concomitant use. In one case, a 33-year-old male with a previously stable INR had an elevated INR of 4.65 after L-carnitine was started and continued for 10 weeks. INR normalized after discontinuation of the L-carnitine-containing product.
Thyroid Hormone
Theoretically, L-carnitine might decrease the effectiveness of thyroid hormone replacement.
L-carnitine appears to act as a peripheral thyroid hormone antagonist by inhibiting entry of thyroid hormone into the nucleus of cells. Taking L-carnitine also seems to diminish some of the symptoms of hyperthyroidism.
Warfarin (Coumadin)
Theoretically, L-carnitine might increase the anticoagulant effects of warfarin.
L-carnitine might increase the anticoagulant effects of acenocoumarol, a shorter-acting oral anticoagulant similar to warfarin. There is not enough information to know whether this interaction occurs with L-carnitine and warfarin.
L-carnitine: Uses, Safety & Side Effects
L-carnitine is a compound your body makes naturally and also gets from foods like meat. It helps cells turn fat into energy, and supplements are most clearly useful for people with a true carnitine deficiency. For most other uses, like weight loss or boosting athletic performance, the evidence is mixed or limited, so talk with your pharmacist or doctor before trying it.
- Common forms
- Capsules, tablets, oral liquid, powder, and injectable (prescription) forms
- Exercise performance and recovery
- Heart health
- Weight management
- Energy and fatigue
- Male fertility
- Carnitine deficiency
Popular and traditional uses — not proof it works. See “Uses & effectiveness” below for the evidence.
Generally well tolerated at typical doses, but high doses can cause stomach upset and a fishy body odor.
Insufficient reliable information available; avoid using.
Read the full pregnancy detailWhen used orally. Supplemental doses of L-carnitine have been given to infants in breast milk and formula with no reported adverse effects. The effect...
Read the full breastfeeding detailPregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center). Safety guidance is general; always confirm with your pharmacist or doctor for your situation.
Overview
L-carnitine is a natural substance made in the body, mostly in the liver and kidneys, from the amino acids lysine and methionine. It is also found in foods, especially red meat, fish, poultry, and dairy. Because your body makes it and you get it from food, most healthy people have enough without taking supplements.
L-carnitine plays a key role in how cells produce energy. It helps move fatty acids into the parts of cells called mitochondria, where they are burned for fuel. This is why it is often marketed for energy, exercise, and weight loss.
Supplements come in several forms, including L-carnitine, acetyl-L-carnitine, and L-carnitine L-tartrate. People take it for many reasons, but the strongest medical use is treating a genuine carnitine deficiency, which can happen with certain genetic conditions, kidney dialysis, or some medications.
How it works
L-carnitine's main job is to act like a shuttle for fats. It helps carry long-chain fatty acids into the mitochondria, the tiny "power plants" inside cells, where those fats are broken down to make energy.
Because of this role, researchers have studied whether extra L-carnitine could improve energy use in muscles, the heart, and other tissues. It may also help clear out certain waste products from cells and has been studied for possible effects on blood vessels and inflammation.
Many of these proposed effects come from laboratory and animal studies, or from small human trials. That means the way L-carnitine behaves in a test tube does not always translate into clear benefits for people.
Does L-carnitine work?
How to read these evidence grades
Natural Medicines’ 7-point scale. We show each rating’s label word-for-word.
Effective L-carnitine deficiency
Oral and intravenous L-carnitine can treat primary and secondary L-carnitine deficiency.
Possibly Effective Angina
Oral and intravenous L-carnitine may improve exercise tolerance and symptoms of angina during exercise in patients with angina.
Possibly Effective Congestive heart failure (CHF)
Oral and intravenous L-carnitine may improve exercise capacity and symptoms of heart failure in patients with CHF.
Possibly Effective Hyperlipidemia
Oral or intravenous L-carnitine may slightly improve lipid levels. Oral, but not intravenous, L-carnitine may also improve lipoprotein(a) levels in patients with elevated lipoprotein(a).
Possibly Effective Kidney failure
Intravenous, but not oral, L-carnitine is FDA-approved for the prevention and treatment of L-carnitine deficiency in patients with kidney failure undergoing hemodialysis. Any other benefits with the use of L-carnitine in patients on hemodialysis are unclear.
Possibly Effective Myocarditis
Oral DL-carnitine may prevent myocarditis in children with diphtheria.
Possibly Effective Valproic acid-induced toxicities
Although more well-designed research is needed to confirm these findings, oral and intravenous L-carnitine may improve neurologic and hepatic function and reduce ammonia levels in patients with these valproic acid-induced toxicities.
Also studied for 69 conditions — evidence insufficient to rate
Insufficient Reliable Evidence To Rate Acne
Topical L-carnitine has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Age-related fatigue
Small clinical studies suggest that oral L-carnitine may improve physical and mental fatigue associated with aging.
Insufficient Reliable Evidence To Rate Aluminum phosphide poisoning
It is unclear if intravenous L-carnitine is beneficial in people with aluminum phosphide poisoning.
Insufficient Reliable Evidence To Rate Alzheimer disease
Oral L-carnitine has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Androgenic alopecia
It is unclear if topical L-carnitine is beneficial in people with androgenic alopecia.
Insufficient Reliable Evidence To Rate Anorexia nervosa
Although there has been interest in using oral L-carnitine for anorexia nervosa, there is insufficient reliable information about the clinical effects of L-carnitine for this purpose.
Insufficient Reliable Evidence To Rate Anthracycline cardiotoxicity
Oral and intravenous L-carnitine have only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Arrhythmia
Small clinical studies suggest that oral L-carnitine may reduce the incidence of arrhythmias in patients with premature ventricular contractions.
Insufficient Reliable Evidence To Rate Asthenopia (eye strain)
Oral L-carnitine has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Athletic performance
Oral L-carnitine has been evaluated for its effect on athletic performance in several small and short-term clinical studies, with mixed results.
Insufficient Reliable Evidence To Rate Atrial fibrillation
It is unclear if oral L-carnitine is beneficial for preventing postoperative atrial fibrillation in patients undergoing aortic valve surgery.
Insufficient Reliable Evidence To Rate Attention deficit-hyperactivity disorder (ADHD)
It is unclear if oral L-carnitine is beneficial in children with ADHD.
Insufficient Reliable Evidence To Rate Autism spectrum disorder
Small clinical studies suggest that oral L-carnitine may improve some symptoms of autism spectrum disorder.
Insufficient Reliable Evidence To Rate Benign prostatic hyperplasia (BPH)
Oral L-carnitine has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Beta-thalassemia
Small clinical studies suggest that oral L-carnitine may improve symptoms and reduce complications of beta-thalassemia minor, intermedia, and major.
Insufficient Reliable Evidence To Rate Cachexia
Small clinical studies suggest that oral L-carnitine may improve body composition and quality of life in patients with cancer-related cachexia.
Insufficient Reliable Evidence To Rate Cancer-related fatigue
It is unclear if oral L-carnitine is beneficial for improving fatigue in patients with advanced cancer.
Insufficient Reliable Evidence To Rate Celiac disease
It is unclear if oral L-carnitine is beneficial in patients with celiac disease.
Insufficient Reliable Evidence To Rate Chemotherapy-related fatigue
It is unclear if oral L-carnitine is beneficial in patients with fatigue due to sunitinib therapy.
Insufficient Reliable Evidence To Rate Chronic fatigue syndrome (CFS)
It is unclear if oral L-carnitine is beneficial in patients with CFS.
Insufficient Reliable Evidence To Rate Chronic obstructive pulmonary disease (COPD)
It is unclear if oral L-carnitine is beneficial in patients with COPD.
Insufficient Reliable Evidence To Rate Cognitive function
It is unclear if oral L-carnitine is beneficial for improving cognitive function in healthy individuals.
Insufficient Reliable Evidence To Rate Coronary heart disease (CHD)
It is unclear if oral L-carnitine is beneficial in patients with CHD.
Insufficient Reliable Evidence To Rate Coronavirus disease 2019 (COVID-19)
It is unclear if oral L-carnitine is beneficial for COVID-19 prevention or treatment.
Insufficient Reliable Evidence To Rate Critical illness (trauma)
It is unclear if oral or nasogastric L-carnitine is beneficial for critical illness.
Insufficient Reliable Evidence To Rate Diabetes
Oral L-carnitine may improve glycemic control in patients with diabetes, but it is unclear if these improvements are clinically meaningful. It is also unclear if L-carnitine can improve lipid profiles or weight loss in these patients.
Insufficient Reliable Evidence To Rate Dilated cardiomyopathy
Small clinical studies suggest that oral L-carnitine may improve ejection fraction in children with dilated cardiomyopathy and adults with ischemic cardiomyopathy.
Insufficient Reliable Evidence To Rate Dry eye
Topical L-carnitine has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Endometriosis
Although there has been interest in using oral L-carnitine for endometriosis, there is insufficient reliable information about the clinical effects of L-carnitine for this purpose.
Insufficient Reliable Evidence To Rate Erectile dysfunction (ED)
Oral L-carnitine has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Exercise-induced muscle damage
It is unclear if oral L-carnitine tartrate is beneficial for exercise recovery.
Insufficient Reliable Evidence To Rate Exercise-induced muscle soreness
Small clinical studies suggest that oral L-carnitine may slightly reduce exercise-induced muscle soreness.
Insufficient Reliable Evidence To Rate Hepatic encephalopathy
Oral or intravenous L-carnitine may improve biochemical markers of disease severity in patients with hepatic encephalopathy, but L-carnitine does not seem to improve clinically important outcomes such as fatigue, quality of life, or overall disease severity.
Insufficient Reliable Evidence To Rate Hepatitis B
Oral L-carnitine has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Hepatitis C
Small clinical studies suggest that oral L-carnitine may improve response to treatment and markers of liver function in patients with hepatitis C.
Insufficient Reliable Evidence To Rate HIV/AIDS
Although there has been interest in using intravenous L-carnitine to increase CD4 counts in patients with HIV/AIDS, there is insufficient reliable information about the clinical effects of L-carnitine for this purpose.
Insufficient Reliable Evidence To Rate Hypertension
It is unclear if oral L-carnitine is beneficial for reducing systolic or diastolic blood pressure.
Insufficient Reliable Evidence To Rate Hyperthyroidism
It is unclear if oral L-carnitine is beneficial in patients with hyperthyroidism.
Insufficient Reliable Evidence To Rate Hypertriglyceridemia
It is unclear if oral L-carnitine is beneficial in patients with hypertriglyceridemia.
Insufficient Reliable Evidence To Rate Hypothyroidism
It is unclear if oral L-carnitine is beneficial for improving fatigue in patients with hypothyroidism.
Insufficient Reliable Evidence To Rate Infertility
It is unclear if oral L-carnitine is beneficial for female infertility.
Insufficient Reliable Evidence To Rate Intermittent claudication
Although there has been interest in using oral L-carnitine for intermittent claudication, there is insufficient reliable information about the clinical effects of L-carnitine for this purpose.
Insufficient Reliable Evidence To Rate Liver disease
Small clinical studies suggest that oral L-carnitine may modestly improve some, but not all, lipid parameters in adults with liver disease.
Insufficient Reliable Evidence To Rate Liver transplant
It is unclear if oral L-carnitine is beneficial in patients awaiting a liver transplant.
Insufficient Reliable Evidence To Rate Low birth weight
It is unclear if oral or intravenous L-carnitine is effective for increasing body weight in preterm infants. Several small clinical studies show conflicting results.
Insufficient Reliable Evidence To Rate Lyme disease
Although there has been interest in using oral L-carnitine for Lyme disease, there is insufficient reliable information about the clinical effects of L-carnitine for this purpose.
Insufficient Reliable Evidence To Rate Malnutrition
It is unclear if oral L-carnitine is beneficial in children with severe malnutrition.
Insufficient Reliable Evidence To Rate Metabolic syndrome
It is unclear if oral or intravenous L-carnitine is beneficial in patients with metabolic syndrome.
Insufficient Reliable Evidence To Rate Migraine headache
It is unclear if oral L-carnitine is beneficial in patients with migraine headaches.
Insufficient Reliable Evidence To Rate Multiple sclerosis-related fatigue
It is unclear if oral L-carnitine is beneficial in patients with multiple sclerosis-related fatigue.
Insufficient Reliable Evidence To Rate Muscle cramps
It is unclear if oral L-carnitine is beneficial in patients with muscle cramps.
Insufficient Reliable Evidence To Rate Myocardial infarction (MI)
It is unclear if oral or intravenous L-carnitine is beneficial in patients who have experienced an MI.
Insufficient Reliable Evidence To Rate Narcolepsy
It is unclear if oral L-carnitine is beneficial in patients with narcolepsy.
Insufficient Reliable Evidence To Rate Neonatal apnea
It is unclear if intravenous L-carnitine is beneficial for preventing neonatal apnea in premature infants.
Insufficient Reliable Evidence To Rate Nonalcoholic fatty liver disease (NAFLD)
It is unclear if oral L-carnitine is beneficial in children and adults with NAFLD.
Insufficient Reliable Evidence To Rate Nonalcoholic steatohepatitis (NASH)
It is unclear if oral L-carnitine is beneficial in patients with NASH.
Insufficient Reliable Evidence To Rate Obesity
Oral L-carnitine seems to have a small effect on weight loss in overweight or obese individuals when taken for up to 6 months, but some conflicting results exist. Doses of 2 grams daily seem to offer the most benefit.
Insufficient Reliable Evidence To Rate Osteoarthritis
It is unclear if oral L-carnitine is beneficial in patients with knee osteoarthritis.
Insufficient Reliable Evidence To Rate Pemphigus
Although there has been interest in using oral L-carnitine for glucocorticoid-induced muscle wasting in patients with pemphigus, there is insufficient reliable information about the clinical effects of L-carnitine for this purpose.
Insufficient Reliable Evidence To Rate Peripheral arterial disease (PAD)
It is unclear if oral L-carnitine is beneficial in patients with PAD.
Insufficient Reliable Evidence To Rate Polycystic ovary syndrome (PCOS)
It is unclear if oral L-carnitine is beneficial for improving pregnancy rates or cardiovascular risk in people with PCOS. The effect of L-carnitine on body composition has promising results.
Insufficient Reliable Evidence To Rate Rett syndrome
It is unclear if oral L-carnitine is beneficial in patients with Rett syndrome.
Insufficient Reliable Evidence To Rate Sarcopenia
Oral L-carnitine may be beneficial for preventing sarcopenia in adults over 75 years of age, but not in healthy older females.
Insufficient Reliable Evidence To Rate Sepsis
Small clinical studies suggest that intravenous L-carnitine may not reduce mortality in patients with sepsis, although patients with more severe sepsis may see some benefit.
Insufficient Reliable Evidence To Rate Spinal muscular atrophy
Although there has been interest in using oral L-carnitine for spinal muscular atrophy, there is insufficient reliable information about the clinical effects of L-carnitine for this purpose.
Insufficient Reliable Evidence To Rate Toxin-induced liver damage
Small clinical studies have evaluated oral and intravenous L-carnitine for the management of liver damage caused by different classes of drugs, including antimycobacterial antibiotics and asparaginase-based agents, with promising results.
Insufficient Reliable Evidence To Rate Traumatic brain injury (TBI)
Although there has been interest in using oral L-carnitine for TBI, there is insufficient reliable information about the clinical effects of L-carnitine for this purpose.
Insufficient Reliable Evidence To Rate Urinary tract infections (UTIs)
It is unclear if oral L-carnitine is beneficial in children with UTIs.
Insufficient Reliable Evidence To Rate Venous leg ulcers
Although there has been interest in using oral L-carnitine for venous leg ulcers, there is insufficient reliable information about the clinical effects of L-carnitine for this purpose.
Source & disclaimer. Effectiveness ratings and evidence summaries are provided by Natural Medicines (Therapeutic Research Center) and shown as licensed. Where Natural Medicines hasn’t rated a use, HelloPharmacist’s pharmacists may add their own reviewed rating and evidence (each such entry is labeled). This is educational information, not medical advice — talk with your pharmacist or doctor before starting, stopping, or changing a supplement.
Safety & precautions
For most healthy adults, L-carnitine appears generally safe when taken by mouth at typical supplement doses for short periods. People with a real deficiency are often treated under medical supervision.
Use extra caution if you have kidney disease, since the body handles L-carnitine differently and waste products may build up. People with a history of seizures should also be careful, as some reports link L-carnitine to more frequent seizures. Those with an underactive thyroid should talk to a doctor first.
For pregnancy and breastfeeding, there is not enough reliable safety information, so it is best to avoid supplements unless a healthcare provider recommends them. Always check with your pharmacist or doctor before starting L-carnitine, especially if you have a medical condition or take other medicines.
Side effects
L-carnitine is usually well tolerated, but side effects can include:
- Nausea, stomach upset, or cramping
- Diarrhea
- A fishy body odor, especially at higher doses
- Heartburn or a fishy taste
Less commonly, some people report restlessness or trouble sleeping with certain forms. People with seizure disorders may notice more seizures. If you have unusual or severe symptoms, stop taking it and contact your healthcare provider.
L-carnitine: Reported Adverse Effects
Documented safety reports on L-carnitine from the evidence-graded Natural Medicines (TRC Healthcare) database, shown word-for-word from the licensed record.
Orally and intravenously, L-carnitine is generally well tolerated.
Most Common Adverse Effects:
All routes of administration: Abdominal cramps, abdominal pain, diarrhea, gastritis, heartburn, nausea, reduced appetite, and vomiting. A fish-like body odor has also been reported.
Serious Adverse Effects (Rare):
All routes of administration: Seizures.
Angina Cardiovascular
According to population research, plasma L-carnitine levels are associated with increased risk of cardiovascular disease and major cardiac events. However, oral supplementation with L-carnitine does not appear to be associated with an increased risk of cardiovascular disease. In fact, a meta-analysis of clinical research shows that L-carnitine supplementation is associated with a reduction in all-cause mortality, as well as ventricular arrhythmias and the development of angina and does not increase the development of heart failure or myocardial reinfarction. Also, another meta-analysis suggests that L-carnitine does not affect mortality or cardiovascular outcomes in patients with a previous myocardial infarction.
- Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WH, Bushman FD, Lusis AJ, Hazen SL. Intestinal microbiota metabolism of L-carn
- DiNicolantonio, J. J., Lavie, C. J., Fares, H., Menezes, A. R., and O'Keefe, J. H. L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Mayo Clin Proc. 2013;88(6):544-551.
- Shang R, Sun Z, Li H. Effective dosing of L-carnitine in the secondary prevention of cardiovascular disease: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2014 Jul 21;14:88.
Anorexia Gastrointestinal
Orally and intravenously, L-carnitine has been associated with nausea, epigastric discomfort, vomiting, abdominal cramps, heartburn, gastritis, anorexia, and diarrhea. Orally, diarrhea or colitis symptoms, nausea and abdominal pain, indigestion, and constipation have been reported in various clinical trials.
- Anon. Carnitor (levocarnitine) package insert. Sigma-Tau Pharmaceuticals Inc, Gaithersburg, MD. December 1999.
- Cherchi A, Lai C, Angelino F, et al. Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo-controlled, crossover study. Int J Clin Pharmacol Ther Toxicol 1985;23:569-72.
- Tarighat, Esfanjani A., Mahdavi, R., Ebrahimi, Mameghani M., Talebi, M., Nikniaz, Z., and Safaiyan, A. The effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis. Biol.Trace Elem.Res 2012;150(1-3):
- An JH, Kim YJ, Kim KJ, et al. L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment: a randomized, double-blind, placebo-controlled trial. Endocr J. 2016;63(10):885-95.
- Chen N, Yang M, Zhou M, Xiao J, Guo J, He L. L-carnitine for cognitive enhancement in people without cognitive impairment. Cochrane Database Syst Rev. 2017;3:CD009374.
- Khajeh B, Dashti-Khavidaki S, Nasiri-Toosi M, Mohammadi K, Jafari A. Effects of pre-transplant L-carnitine supplementation on primary graft dysfunction in liver transplant recipients: a pilot, randomized, placebo-controlled clinical trial. Res Pharm Sci.
- Kubota K, Uojima H, Shao X, et al. Additional L-carnitine Reduced the Risk of Hospitalization in Patients with Overt Hepatic Encephalopathy on Rifaximin. Dig Dis 2021.
- Amini L, Yaghini O, Ghazavi M, Aslani N. L-carnitine versus propranolol for pediatric migraine prophylaxis. Iran J Child Neurol 2021;15(2):77-86.
- Shakibaei F, Jelvani D. Effect of adding l -carnitine to risperidone on behavioral, cognitive, social, and physical symptoms in children and adolescents with autism: A randomized double-blinded placebo-controlled clinical trial. Clin Neuropharmacol 2023;4
- Moustafa I, Connolly C, Anis M, Mustafa H, Oosthuizen F, Viljoen M. A prospective study to evaluate the efficacy and safety of vitamin E and levocarnitine prophylaxis against doxorubicin-induced cardiotoxicity in adult breast cancer patients. J Oncol Phar
- Ellaway CM, Williams K, Leonard H, et al. Rett syndrome: randomized controlled trial of L-carnitine. J Child Neurol 1999;14:162-7.
- Plioplys AV, Plioplys S. Amantadine and L-carnitine treatment of Chronic Fatigue Syndrome. Neuropsychobiology 1997;35:16-23.
- Ciacci C, Peluso G, Iannoni E, et al. L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study. Dig Liver Dis 2007;39:922-8.
- Lebrun C, Alchaar H, Candito M, et al. Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue. Mult Scler 2006;12:321-4.
- Malaguarnera M, Cammalleri L, Gargante MP, et al. L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial. Am J Clin Nutr 2007;86:1738-44.
- Mantovani G, Maccio A, Madeddu C, et al. Randomized phase III clinical trial of five different arms of treatment in 322 patients with cancer cachexia. Oncologist 2010;15:200-11.
- Cruciani, R. A., Dvorkin, E., Homel, P., Culliney, B., Malamud, S., Lapin, J., Portenoy, R. K., and Esteban-Cruciani, N. L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled study. J Pa
- Malaguarnera, M., Vacante, M., Avitabile, T., Malaguarnera, M., Cammalleri, L., and Motta, M. L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes. Am J Clin.Nutr 2009;89(1):71-76.
- Wu, Z. M., Lu, X., Wang, Y. W., Sun, J., Tao, J. W., Yin, F. H., and Cheng, H. J. [Short-term medication of L-carnitine before intracytoplasmic sperm injection for infertile men with oligoasthenozoospermia]. Zhonghua Nan.Ke.Xue 2012;18(3):253-256.
- Madsen KL, Preisler N, Orngreen MC, Andersen SP, Olesen JH, Lund AM, Vissing J. Patients with medium-chain acyl-coenzyme a dehydrogenase deficiency have impaired oxidation of fat during exercise but no effect of L-carnitine supplementation. J Clin Endocri
- Cruciani RA, Dvorkin E, Homel P, et al. Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study. J Pain Symptom Manage 2006;32:551-9.
- Hatamkhani S, Khalili H, Karimzadeh I, Dashti-Khavidaki S, Abdollahi A, Jafari S. Carnitine for prevention of antituberculosis drug-induced hepatotoxicity: a randomized, clinical trial. J Gastroenterol. Hepatol. 2014 May;29(5):997-1004.
- Derosa, G., Cicero, A. F., Gaddi, A., Mugellini, A., Ciccarelli, L., and Fogari, R. The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus. Clin Ther 2003;25(5):1429-1439.
- Kumar, A., Singh, R. B., Saxena, M., Niaz, M. A., Josh, S. R., Chattopadhyay, P., Mechirova, V., Pella, D., and Fedacko, J. Effect of carni Q-gel (ubiquinol and carnitine) on cytokines in patients with heart failure in the Tishcon study. Acta Cardiol. 20
- Zhang JJ, Wu ZB, Cai YJ, Ke B, Huang YJ, Qiu CP, Yang YB, Shi LY, Qin J. L-carnitine ameliorated fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome: a randomized controlled study. Nutr J. 2014 Nov 26;13:110.
- Boehm G, Stahl B. Oligosaccharides from milk. J Nutr 2007;137(3 Suppl 2):847S-849S.
Body odor Other
Orally or intravenously, L-carnitine has been associated with a fish-like body odor. One of its metabolites, trimethylamine N-oxide, can cause the urine, breath, and sweat to have a fishy odor.
- Ellaway CM, Williams K, Leonard H, et al. Rett syndrome: randomized controlled trial of L-carnitine. J Child Neurol 1999;14:162-7.
- Anon. Carnitor (levocarnitine) package insert. Sigma-Tau Pharmaceuticals Inc, Gaithersburg, MD. December 1999.
- Van Oudheusden, L. J. and Scholte, H. R. Efficacy of carnitine in the treatment of children with attention-deficit hyperactivity disorder. Prostaglandins Leukot.Essent.Fatty Acids 2002;67(1):33-38.
- Huang, W. W., Wang, M. Y., Shi, H. M., Peng, Y., Peng, C. S., Zhang, M., Li, Y., Lu, J., and Li, X. B. Comparative study of bioactive constituents in crude and processed Glycyrrhizae radix and their respective metabolic profiles in gastrointestinal tract
- Madsen KL, Preisler N, Orngreen MC, Andersen SP, Olesen JH, Lund AM, Vissing J. Patients with medium-chain acyl-coenzyme a dehydrogenase deficiency have impaired oxidation of fat during exercise but no effect of L-carnitine supplementation. J Clin Endocri
- Evans AM, Fornasini G. Pharmacokinetics of L-carnitine. Clin Pharmacokinet 2003;42:941-67.
- Alvarez, T. M., Guardiola, P. D., Roldan, J. O., Elviro, R., Wevers, R., and Guijarro, G. [Primary trimethylaminuria: the fish odor syndrome]. Endocrinol.Nutr. 2009;56(6):337-340.
Cluster headache Neurologic/CNS
Orally or intravenously, L-carnitine has been associated with seizures. Orally, use of L-carnitine in clinical trials has resulted in headache, although this event is rare. L-carnitine may also cause agitation.
- Anon. Carnitor (levocarnitine) package insert. Sigma-Tau Pharmaceuticals Inc, Gaithersburg, MD. December 1999.
- Malaguarnera, M., Vacante, M., Avitabile, T., Malaguarnera, M., Cammalleri, L., and Motta, M. L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes. Am J Clin.Nutr 2009;89(1):71-76.
- Chen N, Yang M, Zhou M, Xiao J, Guo J, He L. L-carnitine for cognitive enhancement in people without cognitive impairment. Cochrane Database Syst Rev. 2017;3:CD009374.
- Moustafa I, Connolly C, Anis M, Mustafa H, Oosthuizen F, Viljoen M. A prospective study to evaluate the efficacy and safety of vitamin E and levocarnitine prophylaxis against doxorubicin-induced cardiotoxicity in adult breast cancer patients. J Oncol Phar
Hypophosphatemia Hematologic
In one case report, L-carnitine 990 mg twice daily was started in a female presenting to hospital with valproic acid toxicity. Blood phosphorous levels subsequently fell from 2.3 mg/dL to 1.3 mg/dL over 4 days. After discontinuation of L-carnitine, blood phosphorus levels increased to 1.8 mg/dL. The authors suggested that the role of L-carnitine in improved protein metabolism may play a role in the declining levels of phosphorous in the blood and increased risk of hypophosphatemia.
Pruritus Dermatologic
Orally, L-carnitine has been reported to cause skin rash in a small number of cases.
Two patients in a hair growth study using topical carnitine reported mild itching and increased dandruff, while a third reported strong itching with reddish bumps and a burning sensation. When a specific formulation containing L-carnitine, licochalcone, and 1,2-decanediol was applied to the face, mild skin dryness and tightness was reported by 12% of volunteers, compared with 4% to 8% of those in the vehicle-only control group.
- Ciacci C, Peluso G, Iannoni E, et al. L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study. Dig Liver Dis 2007;39:922-8.
- Jun DW, Kim BI, Cho YK, Kim HJ, Kwon YO, Park SY, Han SY, Baek YH, Jung YJ, Kim HY, Kim W, Heo J, Woo HY, Hwang SG, Rim KS, Choi JY, Bae SH, Lee YS, Lim YS,Cheong JY, Cho SW, Lee BS, Kim SH, Sohn JH, Kim TY, Paik YH, Kim JK, Lee KS. Efficacy and safety of
- Foitzik, K., Hoting, E., Heinrich, U., Tronnier, H., and Paus, R. Indications that topical L-carnitin-L-tartrate promotes human hair growth in vivo. J Dermatol.Sci 2007;48(2):141-144.
- Angelova-Fischer I, Rippke F, Fischer TW, Neufang G, Zillikens D. A double-blind, randomized, vehicle-controlled efficacy assessment study of a skin care formulation for improvement of mild to moderately severe acne. J Eur Acad Dermatol Venereol. 2013 Jul
Adverse-effects data: Natural Medicines, Therapeutic Research Center
Dosing
There is no single standard dose of L-carnitine that fits everyone, and the right amount depends on the form and the reason for use. Prescription carnitine for true deficiency is dosed by a doctor based on medical needs.
For over-the-counter supplements, the best approach is to follow the directions on the product label and not exceed the recommended amount. Different forms, such as acetyl-L-carnitine or L-carnitine L-tartrate, may be used differently.
Because doses and product quality vary, talk with your pharmacist or doctor before starting, especially if you have kidney problems, take other medicines, or are pregnant or breastfeeding.
L-carnitine & Pregnancy
L-carnitine & Breastfeeding
© 2026 Therapeutic Research Center
Pregnancy & lactation ratings: Natural Medicines, Therapeutic Research Center
References & further reading
The 41 references that drive our L-carnitine monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.
- Ellaway CM, Williams K, Leonard H, et al. Rett syndrome: randomized controlled trial of L-carnitine. J Child Neurol 1999;14:162-7. PubMed
- Anon. Carnitor (levocarnitine) package insert. Sigma-Tau Pharmaceuticals Inc, Gaithersburg, MD. December 1999.
- Cherchi A, Lai C, Angelino F, et al. Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo-controlled, crossover study. Int J Clin Pharmacol Ther Toxicol 1985;23:569-72.
- Plioplys AV, Plioplys S. Amantadine and L-carnitine treatment of Chronic Fatigue Syndrome. Neuropsychobiology 1997;35:16-23. PubMed
- Benvenga S, Ruggeri RM, Russo A, et al. Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Meta
- Martinez E, Domingo P, Roca-Cusachs A. Potentiation of acenocoumarol action by L-carnitine. J Intern Med 1993;233:94.
- Bachmann HU, Hoffmann A. Interaction of food supplement L-carnitine with oral anticoagulant acenocoumarol. Swiss Med Wkly 2004;134:385. PubMed
- Evans AM, Fornasini G. Pharmacokinetics of L-carnitine. Clin Pharmacokinet 2003;42:941-67. PubMed
- 12761 Benvenga S, Amato A, Calvani M, Trimarchi F. Effects of carnitine on thyroid hormone action. Ann N Y Acad Sci 2004;1033:158-67. PubMed
- Ciacci C, Peluso G, Iannoni E, et al. L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study. Dig Liver Dis 2007;39:922-8. PubMed
- Cruciani RA, Dvorkin E, Homel P, et al. Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study. J Pain Symptom Manage 2006;32:551-9. PubMed
- Lebrun C, Alchaar H, Candito M, et al. Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue. Mult Scler 2006;12:321-4. PubMed
- Malaguarnera M, Cammalleri L, Gargante MP, et al. L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial. Am J Clin Nutr 2007;86:1738-44. PubMed
- Mantovani G, Maccio A, Madeddu C, et al. Randomized phase III clinical trial of five different arms of treatment in 322 patients with cancer cachexia. Oncologist 2010;15:200-11.
- Angelova-Fischer I, Rippke F, Fischer TW, Neufang G, Zillikens D. A double-blind, randomized, vehicle-controlled efficacy assessment study of a skin care formulation for improvement of mild to moderately severe acne. J Eur Acad Dermatol Venereol. 2013 Jul PubMed
- Hatamkhani S, Khalili H, Karimzadeh I, Dashti-Khavidaki S, Abdollahi A, Jafari S. Carnitine for prevention of antituberculosis drug-induced hepatotoxicity: a randomized, clinical trial. J Gastroenterol. Hepatol. 2014 May;29(5):997-1004. PubMed
- Boehm G, Stahl B. Oligosaccharides from milk. J Nutr 2007;137(3 Suppl 2):847S-849S.
- Van Oudheusden, L. J. and Scholte, H. R. Efficacy of carnitine in the treatment of children with attention-deficit hyperactivity disorder. Prostaglandins Leukot.Essent.Fatty Acids 2002;67(1):33-38. PubMed
- Derosa, G., Cicero, A. F., Gaddi, A., Mugellini, A., Ciccarelli, L., and Fogari, R. The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus. Clin Ther 2003;25(5):1429-1439. PubMed
- Foitzik, K., Hoting, E., Heinrich, U., Tronnier, H., and Paus, R. Indications that topical L-carnitin-L-tartrate promotes human hair growth in vivo. J Dermatol.Sci 2007;48(2):141-144. PubMed
- Kumar, A., Singh, R. B., Saxena, M., Niaz, M. A., Josh, S. R., Chattopadhyay, P., Mechirova, V., Pella, D., and Fedacko, J. Effect of carni Q-gel (ubiquinol and carnitine) on cytokines in patients with heart failure in the Tishcon study. Acta Cardiol. 20
- Cruciani, R. A., Dvorkin, E., Homel, P., Culliney, B., Malamud, S., Lapin, J., Portenoy, R. K., and Esteban-Cruciani, N. L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled study. J Pa PubMed
- Malaguarnera, M., Vacante, M., Avitabile, T., Malaguarnera, M., Cammalleri, L., and Motta, M. L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes. Am J Clin.Nutr 2009;89(1):71-76. PubMed
- Alvarez, T. M., Guardiola, P. D., Roldan, J. O., Elviro, R., Wevers, R., and Guijarro, G. [Primary trimethylaminuria: the fish odor syndrome]. Endocrinol.Nutr. 2009;56(6):337-340.
- Wu, Z. M., Lu, X., Wang, Y. W., Sun, J., Tao, J. W., Yin, F. H., and Cheng, H. J. [Short-term medication of L-carnitine before intracytoplasmic sperm injection for infertile men with oligoasthenozoospermia]. Zhonghua Nan.Ke.Xue 2012;18(3):253-256.
- Tarighat, Esfanjani A., Mahdavi, R., Ebrahimi, Mameghani M., Talebi, M., Nikniaz, Z., and Safaiyan, A. The effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis. Biol.Trace Elem.Res 2012;150(1-3): PubMed
- DiNicolantonio, J. J., Lavie, C. J., Fares, H., Menezes, A. R., and O'Keefe, J. H. L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Mayo Clin Proc. 2013;88(6):544-551. PubMed
- Huang, W. W., Wang, M. Y., Shi, H. M., Peng, Y., Peng, C. S., Zhang, M., Li, Y., Lu, J., and Li, X. B. Comparative study of bioactive constituents in crude and processed Glycyrrhizae radix and their respective metabolic profiles in gastrointestinal tract
- Madsen KL, Preisler N, Orngreen MC, Andersen SP, Olesen JH, Lund AM, Vissing J. Patients with medium-chain acyl-coenzyme a dehydrogenase deficiency have impaired oxidation of fat during exercise but no effect of L-carnitine supplementation. J Clin Endocri
- Prohaska ES, Muzyk AJ, Rivelli SK. Levocarnitine-induced hypophosphatemia in a hemodialysis patient with acute valproic acid toxicity. J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):E18-9. PubMed
- Shang R, Sun Z, Li H. Effective dosing of L-carnitine in the secondary prevention of cardiovascular disease: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2014 Jul 21;14:88. PubMed
- Zhang JJ, Wu ZB, Cai YJ, Ke B, Huang YJ, Qiu CP, Yang YB, Shi LY, Qin J. L-carnitine ameliorated fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome: a randomized controlled study. Nutr J. 2014 Nov 26;13:110. PubMed
- Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WH, Bushman FD, Lusis AJ, Hazen SL. Intestinal microbiota metabolism of L-carn
- Jun DW, Kim BI, Cho YK, Kim HJ, Kwon YO, Park SY, Han SY, Baek YH, Jung YJ, Kim HY, Kim W, Heo J, Woo HY, Hwang SG, Rim KS, Choi JY, Bae SH, Lee YS, Lim YS,Cheong JY, Cho SW, Lee BS, Kim SH, Sohn JH, Kim TY, Paik YH, Kim JK, Lee KS. Efficacy and safety of
- An JH, Kim YJ, Kim KJ, et al. L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment: a randomized, double-blind, placebo-controlled trial. Endocr J. 2016;63(10):885-95. PubMed
- Chen N, Yang M, Zhou M, Xiao J, Guo J, He L. L-carnitine for cognitive enhancement in people without cognitive impairment. Cochrane Database Syst Rev. 2017;3:CD009374. PubMed
- Khajeh B, Dashti-Khavidaki S, Nasiri-Toosi M, Mohammadi K, Jafari A. Effects of pre-transplant L-carnitine supplementation on primary graft dysfunction in liver transplant recipients: a pilot, randomized, placebo-controlled clinical trial. Res Pharm Sci. PubMed
- Kubota K, Uojima H, Shao X, et al. Additional L-carnitine Reduced the Risk of Hospitalization in Patients with Overt Hepatic Encephalopathy on Rifaximin. Dig Dis 2021. PubMed
- Amini L, Yaghini O, Ghazavi M, Aslani N. L-carnitine versus propranolol for pediatric migraine prophylaxis. Iran J Child Neurol 2021;15(2):77-86.
- Shakibaei F, Jelvani D. Effect of adding l -carnitine to risperidone on behavioral, cognitive, social, and physical symptoms in children and adolescents with autism: A randomized double-blinded placebo-controlled clinical trial. Clin Neuropharmacol 2023;4 PubMed
- Moustafa I, Connolly C, Anis M, Mustafa H, Oosthuizen F, Viljoen M. A prospective study to evaluate the efficacy and safety of vitamin E and levocarnitine prophylaxis against doxorubicin-induced cardiotoxicity in adult breast cancer patients. J Oncol Phar PubMed
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Brands that make products with L-carnitine
684 brands in our database make a supplement containing L-carnitine.
Supplement products with L-carnitine
3,406 products in our database contain L-carnitine. Open any to see its full ingredient list and every drug interaction we check.
Medications associated with L-carnitine depletion
49 medications in our licensed clinical database have been associated with lower L-carnitine levels. An association is not a guarantee — it is a talking point for your pharmacist.
L-carnitine: Common Questions
What is L-carnitine used for, and does it work?
Does L-carnitine interact with prescription medications?
How are L-carnitine interactions rated?
Is it safe to take L-carnitine with my medications?
Where does this L-carnitine interaction information come from?
What is L-carnitine used for?
Does L-carnitine help with weight loss?
Do I need an L-carnitine supplement if I eat meat?
Is L-carnitine safe to take during pregnancy?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Products that contain L-carnitine
A rotating sample of real supplements in our database that list L-carnitine — open any to see its full ingredients and every drug interaction we check.
- L-Carnitine Extra Strength by BRI Nutrition
- Liquid L-Carnitine 1000 mg Citrus Flavor by NOW Sports
- Perfect 3000 Strawberry by Nature's Best
- Essential B Complex by BioSource Labs
- L-Carnitine 1000 by GNC Total Lean
- Arteriozyme by Energique
- AminoLean Blackberry Pomegranate by RSP
- Liquid L-Carnitine Wild Cherry Flavor by Beauty Trim
- Rush Fruit Punch by BPI
- L-Carnitine LS3 3000 Gummy Bear by iSatori
Have a question about L-carnitine?
Our pharmacists answer your medication & supplement questions — free.